PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-36.35%
Both yoy net incomes decline, with MRVL at -71.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5.42%
Some D&A expansion while MRVL is negative at -26.00%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
38.10%
Deferred tax of 38.10% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
41.63%
SBC growth of 41.63% while MRVL is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
123.12%
Well above MRVL's 132.79% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-95.75%
AR is negative yoy while MRVL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
1839.83%
Inventory growth well above MRVL's 241.87%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
103.38%
AP growth of 103.38% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-214.54%
Negative yoy usage while MRVL is 129.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-110.28%
Both negative yoy, with MRVL at -103.33%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
816.19%
Operating cash flow growth above 1.5x MRVL's 32.42%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
51.65%
CapEx growth well above MRVL's 22.86%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-162.41%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
137.66%
Liquidation growth of 137.66% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
100.00%
Growth well above MRVL's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
71.60%
Investing outflow well above MRVL's 41.59%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
481.78%
We slightly raise equity while MRVL is negative at -96.84%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.